Global Multiplex Assays Market, By Products and Services (Reagents and Consumables, Instruments and Accessories and Software and Services), Type (Nucleic Acid Multiplex Assays, Protein Multiplex Assays and Cell-Based Multiplex Assays), Technology (Protein Microarray, Polymerase Chain Reaction, Multiplex Real-Time PCR, Flow Cytometry, Fluorescence Detection, Luminescence and Others), Application (Clinical Diagnostics and Research and Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Data Bridge Market Research analyses that the multiplex assays market will exhibit a CAGR of around 6.63% for the forecast period of 2021-2028. Rising prevalence of chronic disorders, increased focus on research and development proficiencies in regards to medical devices and on the adoption of advanced healthcare technologies, growing development in nanotechnology and equipment and rising expenditure for the development of healthcare infrastructure development especially in the developing economies are the major factors attributable to the growth of multiplex assays market.
From the name itself, it is clear that multiple assays are the assays that are used measure and run multiple analytes such as proteins, biomolecules, growth factors and cytokines in a single cycle. The assays are used to amplify multiple targets and gain more information from minute quantities of proteins or other analytes in lesser time.
Upsurge in the prevalence of cancer globally is one of the major factors fostering the growth of the market. Surging geriatric population base coupled with growing awareness about the benefits of multiplex assays is another market growth determinant. Rising health awareness among the individuals, growing adoption of companion diagnostics for increasing the safety and efficacy of therapies and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
However, high capital investment and unfavourable reimbursement scenario in the developing and underdeveloped economies will derail the market growth rate. Also, stringent government regulations for product approvals will further pose challenges for the market. Dearth of skilled professionals in the backward economies will also hamper the market growth rate.
This multiplex assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on multiplex assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Multiplex Assays Market Scope and Market Size
The multiplex assays market is segmented on the basis of products and services, type, technology, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the multiplex assays market is segmented into reagents and consumables, instruments and accessories and software and services.
- On the basis of type, the multiplex assays market is segmented into protein multiplex assays, nucleic acid multiplex assays and cell-based multiplex assays. Protein multiplex assays are sub-segmented into planar protein assays and bead-based protein assays. Nucleic acid multiplex assays are sub-segmented into planar nucleic acid assays and bead-based nucleic acid assays.
- On the basis of technology, the multiplex assays market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR, polymerase chain reaction (PCR), protein microarray and others.
- On the basis of application, the multiplex assays market is segmented into research and development and clinical diagnostics. Research and development is sub-segmented into drug discovery & development and biomarker discovery and validation. Clinical diagnostics is sub-segmented into infectious diseases, cancer, cardiovascular diseases, infectious diseases, autoimmune diseases, allergies, nervous system disorders, metabolism and endocrinology disorders and others.
- On the basis of end user, the multiplex assays market is segmented into pharmaceutical and biotechnology companies, research institutes, hospitals, clinical laboratories and others.
Multiplex Assays Market Country Level Analysis
The multiplex assays market is segmented on the basis of products and services, type, technology, application and end user.
The countries covered in the multiplex assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the multiplex assays market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increasing prevalence of chronic disorders and growing adoption of multiplex assays. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the rising research and development proficiencies, number of patients suffering from chronic diseases, improving health care infrastructure and ever-rising geriatric population.
The country section of the multiplex assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The multiplex assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the multiplex assays market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Multiplex Assays Market Share Analysis
The multiplex assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to multiplex assays market.
The major players covered in the multiplex assays market report are Thermo Fisher Scientific Inc., Luminex Corporation., BD, QIAGEN, Agilent Technologies, Inc., MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Bio-Techne., Seegene Inc., Olink, Illumina, Inc., Bio-Rad Laboratories, Inc., Quanterix, Abcam plc., Sysmex Corporation, F. Hoffmann-La Roche Ltd, Hologic, Inc., DiaSorin S.p.A.,, Quest Diagnostics Incorporated and Abbott among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Multiplex Assays Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.